Katsumasa Nakamura1, Saiji Ohga2, Atsunori Yorozu3, Shiro Saito4, Takashi Kikuchi5, Takushi Dokiya6, Masanori Fukushima5, Hidetoshi Yamanaka7. 1. Department of Radiation Oncology, Hamamatsu University School of Medicine, Handayama 1‑20-1, Higashi-ku, 431-3192, Hamamatsu, Japan. nakam@hama-med.ac.jp. 2. Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. 3. Department of Radiology, National HospitalOrganization Tokyo Medical Center, Tokyo, Japan. 4. Department of Urology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan. 5. Translational Research Center for Medical Innovation, Hyogo, Japan. 6. Department of Radiology, Sasaki Foundation Kyoundo Hospital, Tokyo, Japan. 7. Japanese Foundation for Prostate Research, Tokyo, Japan.
Abstract
PURPOSE: It is unclear whether experience at high-volume institute improves the treatment quality of prostate seed implantation. The aim of this study was to evaluate the effect of institutional experience on postimplant dosimetric parameters in a nationwide prospective cohort study. METHODS: From July 2005 to June 2007, 2354 patients were registered in the Japanese Prostate Cancer Outcome Study of Permanent I‑125 Seed Implantation (J-POPS), and 1126 patients treated with seed implantation alone were evaluated. As a surrogate for institutional experience, we classified the J‑POPS institutions as high-volume (patient accrual volume was ≥120 patients per institution) or low-volume institutions (patient accrual volume was <120 patients per institution). To compare treatment quality between institutions, we evaluated the postimplant dosimetric parameters including D90, V100/150 (prostatic dose parameters), UD5/90, U200 (urethral dose parameters), and rectum R100/150 (rectal dose parameters). RESULTS: In the 5 high-volume institutions (n = 601 patients), most of the patients were treated with >144 Gy of D90, whereas in the 20 low-volume institutions (n = 525) some of the patients were treated with <144 Gy. The V100 of most of the high-volume institution patients were >90%, whereas in the low-volume institutions a considerable percentage of patients showed lower V100. Although there was no correlation between D90 and rectal dose parameters, UD90 had a moderate positive correlation with D90 in both the high- and low-volume institutions. U200 varied more widely in the low-volume institutions. CONCLUSIONS: Our findings indicate that the institutional patient accrual volume is associated with the treatment quality of I‑125 prostate seed implantation.
PURPOSE: It is unclear whether experience at high-volume institute improves the treatment quality of prostate seed implantation. The aim of this study was to evaluate the effect of institutional experience on postimplant dosimetric parameters in a nationwide prospective cohort study. METHODS: From July 2005 to June 2007, 2354 patients were registered in the Japanese Prostate Cancer Outcome Study of Permanent I‑125 Seed Implantation (J-POPS), and 1126 patients treated with seed implantation alone were evaluated. As a surrogate for institutional experience, we classified the J‑POPS institutions as high-volume (patient accrual volume was ≥120 patients per institution) or low-volume institutions (patient accrual volume was <120 patients per institution). To compare treatment quality between institutions, we evaluated the postimplant dosimetric parameters including D90, V100/150 (prostatic dose parameters), UD5/90, U200 (urethral dose parameters), and rectum R100/150 (rectal dose parameters). RESULTS: In the 5 high-volume institutions (n = 601 patients), most of the patients were treated with >144 Gy of D90, whereas in the 20 low-volume institutions (n = 525) some of the patients were treated with <144 Gy. The V100 of most of the high-volume institution patients were >90%, whereas in the low-volume institutions a considerable percentage of patients showed lower V100. Although there was no correlation between D90 and rectal dose parameters, UD90 had a moderate positive correlation with D90 in both the high- and low-volume institutions. U200 varied more widely in the low-volume institutions. CONCLUSIONS: Our findings indicate that the institutional patient accrual volume is associated with the treatment quality of I‑125 prostate seed implantation.
Authors: Carl Salembier; Pablo Lavagnini; Philippe Nickers; Paola Mangili; Alex Rijnders; Alfredo Polo; Jack Venselaar; Peter Hoskin Journal: Radiother Oncol Date: 2007-02-26 Impact factor: 6.280
Authors: Claudio Jeldres; Nazareno Suardi; Fred Saad; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Naeem Bhojani; Jochen Walz; Georg C Hutterer; Markus Graefen; Luc Valiquette; Pierre I Karakiewicz Journal: Eur Urol Date: 2007-11-06 Impact factor: 20.096
Authors: Christopher R Loiselle; Musaddiq Waheed; John Sylvester; Zachariah A Allen; Peter D Grimm; Steven Eulau; Wayne M Butler; Gregory S Merrick Journal: Brachytherapy Date: 2008-12-03 Impact factor: 2.362
Authors: Mira Keyes; Stacy Miller; Veronika Moravan; Tom Pickles; Michael McKenzie; Howard Pai; Mitchell Liu; Winkle Kwan; Alexander Agranovich; Ingrid Spadinger; Vincent Lapointe; Ross Halperin; W James Morris Journal: Int J Radiat Oncol Biol Phys Date: 2008-12-26 Impact factor: 7.038
Authors: Matthias Moll; Andreas Renner; Christian Kirisits; Christopher Paschen; Alexandru Zaharie; Gregor Goldner Journal: Strahlenther Onkol Date: 2021-08-05 Impact factor: 3.621